Contracts › 75N98026F00001
75N98026F00001: Exploratory Chemistry and Hit-To-Lead Chemistry Option. Medicinal Chemistry Support Program for Therapeutic Development (MCSP). Pop: September 21, 2026 to March 20, 2029. Dap-Ncap-00000137
Awarded to Curia Global Inc by National Institutes of Health (NIH).
$2.1Mobligated
$3.8Mpotential value
20 March 2029current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N98026F00001 |
|---|---|
| Vehicle | HHSN271201800001I |
| Awardee | Curia Global Inc |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH OLAO |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NY |
| Period of performance | 21 September 2026 to 20 March 2029 |
| Potential end | 20 March 2029 |
| Estimated recompete solicitation | ~Q3 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record